UnknownNot Applicable

Immunohematology in COVID-19 Patients: A Hospital-based Retrospective Cohort Study

China2,000 participantsStarted 2020-01-01

Plain-language summary

This is a hospital-based retrospective cohort study and the Immunohematologic characteristics of COVID-19 patients will be investigated systematically.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * The patients who were diagnosed with COVID-19 following the WHO interim guidelines (https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novelcoronavirus-(ncov)-infection-is-suspected. 2020.) Exclusion Criteria: * Male or female patients \<18 years of age

What they're measuring

ABO and Rh distribution

Timeframe: 1 year

ABO antibody titers

Timeframe: 1 year

Trial details

NCT IDNCT04932954

SponsorLI YAN

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-01-01

View on ClinicalTrials.gov More Covid19 trials